查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1995209

脊髓帮浦市场：2026-2032年全球市场预测（依产品类型、适应症、技术、最终用户及通路划分）

Spinal Pumps Market by Product Type, Indication, Technology, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，脊椎帮浦市场价值将达到 3.4754 亿美元，到 2026 年将成长至 3.7684 亿美元，到 2032 年将达到 5.9434 亿美元，年复合成长率为 7.96%。

主要市场统计数据
基准年 2025 3.4754亿美元
预计年份：2026年 3.7684亿美元
预测年份 2032 5.9434亿美元
复合年增长率 (%) 7.96%

对脊髓帮浦生态系统进行全面概述，重点在于临床因素、技术进步、监管压力和相关人员的需求。

脊髓帮浦（也称为鞘内药物传递系统）是介入性疼痛管理、神经病学和復健医学的交叉领域。随着设备耐用性、程式设计柔软性和植入技术的进步，其在为难治性疼痛和痉挛提供标靶治疗的作用也在不断发展。近年来，临床医生和医疗采购人员更加重视治疗方法，因此，支持个体化剂量设定和递增的植入式系统越来越受到关注。

数位整合、小型化、医疗保健服务环境的转变以及不断变化的法规，这些变革正在重新定义脊椎帮浦的开发和护理路径。

在脊髓帮浦领域，正在发生多项变革性变化，这些变化正在重新定义产品设计、治疗路径和商业化策略。诸如增强的可编程性、更聪明的电池管理以及与数位监测平台的整合等技术进步，使得更精细的剂量调整和远端治疗监测成为可能，这正在改变临床医生在院外管理慢性疾病的方式。

美国关税措施对脊椎帮浦的供应链、定价结构、临床应用和策略製造决策的累积影响。

美国将于2025年实施的新关税正在对医疗设备的生产、采购和病患取得产生连锁反应，而且这种影响是累积的，而非孤立的。在原料投入阶段，对电子元件、精密聚合物和辅助手术器械征收的关税将推高依赖全球供应链的製造商的采购成本。为了应对这项挑战，一些公司正在加速推动近岸外包和双重采购策略以降低风险，但这需要对本地生产能力、认证流程和供应链重组进行资本投资。

深入的細項分析揭示了产品类型、最终用户、临床适应症、泵浦技术和分销模式的需求趋势。

细分市场分析揭示了每种产品类型、最终用户、适应症、技术和分销管道的微妙需求趋势和明确的商业性意义。按产品类型划分，不可充电式和可充电式植入之间的市场分化影响着临床医生的选择。当优先考虑便利性和较低的初始投资时，不可充电式设备往往更受欢迎；而可充电式系统则吸引了那些重视长使用寿命和减少更换次数的临床医生。依最终使用者划分，门诊手术中心、医院和专科疼痛诊所的部署模式各不相同，它们对存货周转、植入支援和术后追踪的要求也各不相同。

区域洞察揭示全球市场的采用模式、监管细微差别、还款差异和供应链考量。

区域趋势对美洲、欧洲、中东和非洲以及亚太地区的监管时间表、报销途径、临床应用和供应链物流均有显着影响。在美洲，临床医生在硬膜外治疗方面的熟练程度以及提供先进治疗的专科机构的集中，往往会加速产品的引入，但保险公司的审查和医院的采购週期会导致采购时间和高级功能的报销资格存在差异。同时，在欧洲、中东和非洲，不同的法规结构和报销模式，以及各国卫生经济状况和医疗设备分类的差异，都会影响产品推出的顺序和证据要求。

脊椎帮浦产业的企业策略和竞争对手趋势正在影响产品创新、策略联盟、售后服务和商业化策略。

脊髓帮浦产业的企业策略体现了产品创新、售后服务和策略合作的整合，旨在扩大临床价值和商业性覆盖范围。市场领导者倾向于投资于可整合到服务交付中的迭代式设备改进，例如患者支援、耗材补充管理和治疗结果追踪，包括可程式设计介面、电池效率和远端监测。小规模的创新者和Start-Ups往往推动颠覆性架构和特定临床功能的开发，因此对于寻求快速拓展产品组合的大型企业而言，它们是极具吸引力的合作伙伴。

脊椎帮浦产业的领导者提出切实可行的策略建议，以加速负责任的创新、优化商业模式并增强供应链韧性。

产业领导者应优先采取一系列行动，以确保临床和商业性优势，同时降低营运风险。首先，他们应将研发投资集中于可程式设计功能和整合监测，从而显着改善患者预后并降低医疗总成本。这种差异化有助于提升产品高端定位，并在与支付方的谈判中更具优势。其次，他们应透过结合区域契约製造和战略库存缓衝，实现供应链多元化，以应对关税造成的成本衝击和前置作业时间波动。第三，他们应积极与门诊手术中心和专科诊所合作，透过建立整合式照护路径，简化植入手术和术后追踪流程，从而提高处理能力并改善病患体验。

一套完善的调查方法，说明如何整合一级和二级调查、与临床医生的对话、监管审查和供应链情境分析。

本报告的分析整合了与临床医生、医院采购经理和支付方代表的直接访谈，以及对监管申报文件、临床文献、医疗设备註册资料和供应链资料的系统性审查。主要研究包括对疼痛管理、神经病学和復健领域的关键意见领袖（KOL）进行详细访谈和结构化调查，以深入了解医疗设备的实际使用情况、临床偏好以及推广应用的障碍。次要证据包括同行评审的研究、监管指导文件以及公开的临床实践和报销框架，以阐明临床和商业性驱动因素。

简明扼要的结论重点强调了临床、商业性、监管和供应链的优先事项，这些事项将决定脊髓帮浦疗法的短期进展。

总之，脊髓帮浦生态系统正受到多种因素的共同影响而发生重组：技术进步使得鞘内治疗的个人化成为可能；医疗服务模式向门诊转移；支付方对可验证价值的期望日益提高；以及外部贸易趋势对价值链韧性和成本结构的影响。产品类型、最终用户、适应症、技术和通路等方面的细微差异表明，统一的商业模式成功的可能性很低。相反，个人化证据的建构、跨销售管道的互动以及灵活的定价结构对于促进永续性至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：脊髓帮浦市场：依产品类型划分

  • 不可充电
  • 可充电的

第九章：脊髓帮浦市场：依适应症划分

  • 疼痛管理
  • 痉挛管理

第十章 脊髓帮浦市场：依技术划分

  • 恆速泵浦
  • 可程式泵浦

第十一章：脊椎帮浦市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 疼痛专科诊所

第十二章 脊椎帮浦市场：依通路划分

  • 直销
  • 透过分销商销售

第十三章：脊椎帮浦市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 脊髓帮浦市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 脊椎帮浦市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国脊髓帮浦市场

第十七章：中国脊椎帮浦市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Durect Corporation
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Smiths Medical
  • Teleflex Incorporated
  • Terumo Corporation
  • Tricumed Medizintechnik GmbH
Product Code: MRR-A77F2EE7AB0F

The Spinal Pumps Market was valued at USD 347.54 million in 2025 and is projected to grow to USD 376.84 million in 2026, with a CAGR of 7.96%, reaching USD 594.34 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 347.54 million
Estimated Year [2026] USD 376.84 million
Forecast Year [2032] USD 594.34 million
CAGR (%) 7.96%

Comprehensive introduction to the spinal pumps ecosystem highlighting clinical drivers, technological progress, regulatory pressures, and stakeholder imperatives

Spinal pumps, also known as intrathecal drug delivery systems, sit at the intersection of interventional pain management, neurology, and rehabilitation medicine. Their role in delivering targeted therapy for refractory pain and spasticity has evolved alongside improvements in device longevity, programming flexibility, and implantation techniques. In recent years clinicians and healthcare purchasers have prioritized therapies that reduce systemic exposure to opioids and other systemic agents while improving patient function and quality of life, which in turn has shifted attention toward implantable systems that support personalized dosing and titration.

Simultaneously, advances in rechargeable battery chemistry, programmable control, and device miniaturization have rebalanced clinical trade-offs between fixed-rate simplicity and programmable sophistication. This technical progress intersects with care delivery trends such as the rise of ambulatory surgical centers, tighter hospital budget cycles, and payer demands for demonstrable value. Consequently, stakeholders from clinicians to supply chain managers are re-evaluating device selection criteria, lifecycle costs, patient support services, and real-world evidence generation strategies. As a result, organizations operating in the spinal pump space must align clinical utility with operational feasibility and reimbursement clarity to succeed in an increasingly value-oriented environment.

Transformative shifts redefining spinal pump development and care pathways including digital integration, miniaturization, care setting migration, and regulatory evolution

The landscape for spinal pumps is undergoing several transformative shifts that are redefining product design, care pathways, and commercialization strategies. Technological advances such as enhanced programmability, smarter battery management, and integration with digital monitoring platforms are enabling more nuanced titration and remote oversight of therapies, which is changing how clinicians manage chronic conditions outside of inpatient settings.

Concurrently, miniaturization and improvements in biocompatible materials have lowered procedural complexity and improved patient acceptance, encouraging broader consideration of pump therapy earlier in treatment algorithms. Care delivery migration toward ambulatory surgical centers and outpatient pipelines is influencing device ergonomics, inventory practices, and service models. Payers and health systems continue to demand stronger evidence of comparative effectiveness and long-term outcomes, which drives investment in registries and post-market studies. Finally, regulatory trajectories are emphasizing cybersecurity, software validation, and human factors engineering, prompting manufacturers to embed compliance and life-cycle vigilance into product roadmaps. Together, these shifts catalyze a more interconnected ecosystem in which technology, evidence, and commercial execution must align to capture clinical and economic value.

Projected cumulative impacts of United States tariff measures on spinal pump supply chains, pricing structures, clinical access, and strategic manufacturing decisions

The imposition of new tariff measures in the United States in 2025 has ripple effects across device manufacturing, procurement, and patient access that are cumulative rather than isolated. At the input level, tariffs on electronic components, precision polymers, and ancillary surgical instruments raise landed costs for manufacturers that rely on global supply chains. In response, some firms accelerate nearshoring or dual-sourcing strategies to mitigate exposure, which necessitates capital investment in local manufacturing capacity, qualification processes, and supply chain reconfiguration.

Downstream, higher input costs translate into pricing pressure that manufacturers must manage through cost optimization, contract renegotiations, or differentiation strategies focused on outcomes and service. Hospitals and ambulatory centers, facing tighter capital and operating budgets, may extend device lifecycles, prioritize lower upfront-cost options, or seek bundled procurements to preserve margins. Payers are likely to scrutinize cost increases closely and may demand stronger evidence of clinical benefit to justify higher reimbursement rates. Over time, tariffs can indirectly influence innovation pathways by shifting R&D priorities toward cost-efficient designs, modular architectures that simplify sourcing, and partnerships with contract manufacturers that can amortize tariff impacts. Importantly, resilient commercial strategies will combine supply diversification with clear value demonstration to preserve access for patients while maintaining sustainable manufacturer margins.

Insightful segmentation analysis exposing demand dynamics across product types, end users, clinical indications, pump technologies, and distribution models

Segmentation reveals nuanced pockets of demand and distinct commercial implications across product type, end user, indication, technology, and distribution channel. Based on product type, the market dichotomy between non rechargeable and rechargeable implants shapes clinician selection: non rechargeable devices often appeal where simplicity and lower upfront capital are priorities, whereas rechargeable systems attract clinicians focused on longevity and reduced replacement procedures. Based on end user, adoption patterns diverge among ambulatory surgical centers, hospitals, and specialized pain clinics, with each setting imposing different requirements for inventory turnover, implantation support, and post-operative follow-up.

Based on indication, differentiation between pain management and spasticity management signals varying therapy objectives and outcome metrics, with pain management emphasizing analgesic titration and patient-reported outcomes and spasticity management prioritizing functional gains and caregiver burden reduction. Based on technology, choice between fixed rate pumps and programmable pumps has direct implications for clinical workflows and training; fixed rate options minimize programming complexity while programmable pumps enable individualized dosing strategies and advanced care plans. Based on distribution channel, commercial strategies must account for differences between direct sales and distributor sales, where direct engagement facilitates tighter clinical support and bundled services while distributor pathways offer scale and geographic reach. Overall, successful market approaches tailor device features, clinical evidence generation, and commercial models to the specific needs of each segment to maximize adoption and long-term value.

Regional insights revealing adoption patterns, regulatory nuances, reimbursement variability, and supply chain considerations across global markets

Regional dynamics exert a major influence on regulatory timelines, reimbursement pathways, clinical adoption, and supply chain logistics across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, clinician familiarity with intrathecal therapies and concentrated centers of excellence often accelerate adoption, but payer scrutiny and hospital procurement cycles create variability in time-to-procure and willingness to reimburse advanced features. Conversely, Europe, Middle East & Africa presents a mosaic of regulatory frameworks and reimbursement models where country-level differences in health economics and device classification influence launch sequencing and evidence requirements.

Asia-Pacific markets display heterogeneity as well, with advanced healthcare systems adopting innovative features faster while emerging markets focus on cost-effective solutions and scalability. Manufacturing footprints and supplier ecosystems in Asia-Pacific also make the region central to component sourcing, which ties back to tariff and supply resilience strategies. Across all regions, local clinician education programs, registry participation, and partnerships with health systems shape long-term uptake. Therefore, regional strategies must balance centralized product development with tailored regulatory, reimbursement, and commercial plans that reflect each region's clinical practice patterns and procurement norms.

Corporate strategies and competitive behavior shaping product innovation, strategic alliances, aftermarket services, and commercialization tactics in the spinal pump sector

Corporate strategies in the spinal pump domain reflect a blend of product innovation, aftermarket services, and strategic collaborations designed to extend clinical value and commercial reach. Market leaders tend to invest in iterative device improvements-such as programmable interfaces, battery efficiency, and remote monitoring-that can be integrated into service offerings like patient support, refill management, and outcomes tracking. Smaller innovative firms and startups often drive disruptive architectures or niche clinical capabilities, which can make them attractive partners for larger organizations seeking to broaden portfolios quickly.

Across the competitive landscape, alliances with contract manufacturers, software vendors, and clinical networks are increasingly common as firms seek to accelerate time-to-market while spreading development risk. Pricing strategies reflect a balance between upfront device cost and lifecycle service revenue, with some companies emphasizing bundled approaches that include implantation, follow-up, and device maintenance. Additionally, companies that invest in post-market evidence generation and digital tools to capture real-world outcomes are better positioned to negotiate with payers and support clinician adoption. Overall, nimble commercialization, focused clinical programs, and robust aftermarket services distinguish successful companies in this sector.

Actionable strategic recommendations for industry leaders to accelerate responsible innovation, optimize commercial models, and strengthen supply resilience in spinal pumps

Industry leaders should pursue a set of prioritized actions to capture clinical and commercial advantage while mitigating operational risks. First, align R&D investments toward programmable features and integrated monitoring that demonstrably improve patient outcomes and reduce total cost of care; such differentiation supports premium positioning and more persuasive payer negotiations. Second, diversify supply chains by combining regional contract manufacturing with strategic inventory buffers to absorb tariff-driven cost shocks and lead-time volatility. Third, partner proactively with ambulatory surgical centers and specialized clinics to create integrated care pathways that streamline implantation and follow-up, thereby improving throughput and patient experience.

Fourth, invest in comprehensive evidence generation including registries and post-market studies that track functional outcomes, device durability, and health economic endpoints; use these data to inform tiered reimbursement approaches. Fifth, refine commercial models across direct sales and distributor channels, calibrating training, digital support, and pricing incentives to channel-specific needs. Sixth, develop robust patient support programs that include remote refill reminders, telehealth follow-ups, and adherence monitoring to reduce complications and foster loyalty. When executed in concert, these recommendations strengthen market positioning, reduce operational exposure, and accelerate adoption in a landscape increasingly focused on demonstrable value.

Robust research methodology detailing primary and secondary evidence synthesis, clinician engagement, regulatory review, and supply chain scenario analysis

The analysis underpinning this report synthesizes primary engagement with clinicians, hospital procurement leaders, and payer representatives, combined with a systematic review of regulatory filings, clinical literature, device registries, and supply chain data. Primary research included in-depth interviews and structured surveys with key opinion leaders across pain management, neurology, and rehabilitation disciplines to capture real-world device utilization, clinical preferences, and perceived barriers to adoption. Secondary evidence incorporated peer-reviewed studies, guidance documents from regulatory authorities, and publicly available procedural and reimbursement policy frameworks to contextualize clinical and commercial drivers.

Supply chain mapping relied on supplier disclosures, trade flows, and manufacturing footprint analysis to identify sourcing risks and mitigation pathways. Scenario planning was used to stress-test tariff and reimbursement permutations and to estimate plausible responses by manufacturers and health systems. Quality assurance measures included triangulation across multiple data sources, cross-validation with clinician inputs, and methodological transparency regarding limitations. The result is an evidence-based synthesis that balances clinical insight, regulatory context, and operational considerations to inform strategic decision making without relying on proprietary or single-source assumptions.

Concise concluding synthesis emphasizing clinical, commercial, regulatory, and supply chain priorities that will determine near-term progress in spinal pump care

In conclusion, the spinal pump ecosystem is being reshaped by converging forces: advancing technology that enables personalization of intrathecal therapy; shifts in care delivery toward outpatient settings; heightened payer expectations for demonstrable value; and external trade dynamics that influence supply chain resilience and cost structures. Segmentation nuances-across product type, end user, indication, technology, and distribution-highlight that one-size-fits-all commercial models are unlikely to succeed. Instead, tailored evidence generation, channel-specific engagement, and flexible pricing structures will be critical to drive clinical uptake and long-term sustainability.

Regional differences further underscore the need for localized regulatory and reimbursement strategies, while corporate behavior points to the value of partnerships, aftermarket services, and data-driven outcomes programs. By prioritizing programmable features, integrated monitoring, diversified manufacturing, and robust clinical evidence, stakeholders can navigate tariff-induced cost pressures and evolving clinical expectations. Moving forward, organizations that combine clinical excellence with operational agility and payer-centric value demonstration will be best positioned to translate innovation into improved patient access and durable commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Spinal Pumps Market, by Product Type

  • 8.1. Non Rechargeable
  • 8.2. Rechargeable

9. Spinal Pumps Market, by Indication

  • 9.1. Pain Management
  • 9.2. Spasticity Management

10. Spinal Pumps Market, by Technology

  • 10.1. Fixed Rate Pumps
  • 10.2. Programmable Pumps

11. Spinal Pumps Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialized Pain Clinics

12. Spinal Pumps Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Spinal Pumps Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Spinal Pumps Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Spinal Pumps Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Spinal Pumps Market

17. China Spinal Pumps Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. B. Braun Melsungen AG
  • 18.7. Baxter International Inc.
  • 18.8. Becton, Dickinson and Company
  • 18.9. Boston Scientific Corporation
  • 18.10. Durect Corporation
  • 18.11. Flowonix Medical Inc.
  • 18.12. Fresenius Kabi AG
  • 18.13. ICU Medical, Inc.
  • 18.14. Johnson & Johnson
  • 18.15. Medtronic plc
  • 18.16. Smiths Medical
  • 18.17. Teleflex Incorporated
  • 18.18. Terumo Corporation
  • 18.19. Tricumed Medizintechnik GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SPINAL PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SPINAL PUMPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SPINAL PUMPS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SPINAL PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SPINAL PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SPINAL PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SPINAL PUMPS MARKET SIZE, BY NON RECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SPINAL PUMPS MARKET SIZE, BY NON RECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SPINAL PUMPS MARKET SIZE, BY NON RECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SPINAL PUMPS MARKET SIZE, BY RECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SPINAL PUMPS MARKET SIZE, BY RECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SPINAL PUMPS MARKET SIZE, BY RECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPINAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SPINAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SPINAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SPINAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SPINAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPINAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SPINAL PUMPS MARKET SIZE, BY FIXED RATE PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SPINAL PUMPS MARKET SIZE, BY FIXED RATE PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SPINAL PUMPS MARKET SIZE, BY FIXED RATE PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SPINAL PUMPS MARKET SIZE, BY PROGRAMMABLE PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SPINAL PUMPS MARKET SIZE, BY PROGRAMMABLE PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SPINAL PUMPS MARKET SIZE, BY PROGRAMMABLE PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SPINAL PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SPINAL PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SPINAL PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SPINAL PUMPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SPINAL PUMPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SPINAL PUMPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SPINAL PUMPS MARKET SIZE, BY SPECIALIZED PAIN CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SPINAL PUMPS MARKET SIZE, BY SPECIALIZED PAIN CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SPINAL PUMPS MARKET SIZE, BY SPECIALIZED PAIN CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SPINAL PUMPS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SPINAL PUMPS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SPINAL PUMPS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SPINAL PUMPS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SPINAL PUMPS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPINAL PUMPS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPINAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS SPINAL PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA SPINAL PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SPINAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. GCC SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GCC SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. GCC SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GCC SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. GCC SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GCC SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. G7 SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. G7 SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. G7 SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 117. G7 SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. G7 SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. G7 SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. NATO SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NATO SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NATO SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NATO SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. NATO SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. NATO SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SPINAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA SPINAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA SPINAL PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA SPINAL PUMPS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA SPINAL PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA SPINAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA SPINAL PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)